Home » Genzyme’s Oral Gaucher Therapy Meets Goal of Trial
Genzyme’s Oral Gaucher Therapy Meets Goal of Trial
Genzyme Corp., a Cambridge biotechnology company, said that its experimental oral treatment for Gaucher disease, a rare genetic disorder, met the main goal of a mid-stage clinical trial.
boston.com
boston.com
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May